当前位置:首页 - 行情中心 - 华东医药(000963) - 财务分析 - 现金流量表

华东医药

(000963)

  

流通市值:548.69亿  总市值:548.92亿
流通股本:17.53亿   总股本:17.54亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金10,376,323,259.3847,603,508,452.3535,143,641,924.1923,043,949,397.08
  收到的税费返还2,570,13116,771,253.5915,291,551.755,110,647.25
  收到其他与经营活动有关的现金124,934,981.83853,630,530.93691,105,479.99311,722,673.58
  经营活动现金流入小计10,503,828,372.2148,473,910,236.8735,850,038,955.9323,360,782,717.91
  购买商品、接受劳务支付的现金7,960,726,465.3629,990,020,022.0622,966,598,545.2513,943,183,727.91
  支付给职工以及为职工支付的现金1,542,554,152.985,380,354,732.474,049,472,030.972,692,040,129.25
  支付的各项税费709,327,509.542,934,697,014.282,277,592,721.511,576,435,543.9
  支付其他与经营活动有关的现金1,143,556,006.965,923,234,096.893,945,523,714.022,692,274,806.75
  经营活动现金流出小计11,356,164,134.8444,228,305,865.733,239,187,011.7520,903,934,207.81
  经营活动产生的现金流量净额-852,335,762.634,245,604,371.172,610,851,944.182,456,848,510.1
二、投资活动产生的现金流量:
  收回投资收到的现金-14,700,00014,700,000-
  取得投资收益收到的现金-70,463,762.9649,321,490.4747,347,567.67
  处置固定资产、无形资产和其他长期资产收回的现金净额74,063.5121,100,980.3510,619,487.8310,814,966.49
  投资活动现金流入小计74,063.51106,264,743.3174,640,978.358,162,534.16
  购建固定资产、无形资产和其他长期资产支付的现金261,855,876.921,574,454,008.411,085,447,151.48788,358,827.36
  投资支付的现金129,618,537.85127,677,933.8666,060,77561,560,775
  支付其他与投资活动有关的现金-73,905,213.881,524,947.75-
  投资活动现金流出小计391,474,414.771,776,037,156.151,153,032,874.23849,919,602.36
  投资活动产生的现金流量净额-391,400,351.26-1,669,772,412.84-1,078,391,895.93-791,757,068.2
三、筹资活动产生的现金流量:
  取得借款收到的现金1,131,688,831.323,251,416,517.562,519,372,6481,720,372,646.92
  收到其他与筹资活动有关的现金800,000988,854,695.83220,601,111.1217,401,111.1
  筹资活动现金流入小计1,132,488,831.324,240,271,213.392,739,973,759.11,937,773,758.02
  偿还债务支付的现金1,047,678,831.323,522,627,345.722,642,267,908.351,728,740,028.9
  分配股利、利润或偿付利息支付的现金37,291,974.451,735,408,728.321,758,448,442.051,057,608,222.25
  其中:子公司支付给少数股东的股利、利润-43,280,794.1711,873,140.39-
  支付其他与筹资活动有关的现金12,306,031.361,804,706,799.29701,895,348.32684,856,705.37
  筹资活动现金流出小计1,097,276,837.137,062,742,873.335,102,611,698.723,471,204,956.52
  筹资活动产生的现金流量净额35,211,994.19-2,822,471,659.94-2,362,637,939.62-1,533,431,198.5
四、汇率变动对现金及现金等价物的影响-4,179,294.34-7,589,821.17-6,921,970.54-116,843,004.4
五、现金及现金等价物净增加额-1,212,703,414.04-254,229,522.78-837,099,861.9114,817,239
  加:期初现金及现金等价物余额4,735,921,663.94,990,151,186.684,990,151,186.684,990,151,186.68
  期末现金及现金等价物余额3,523,218,249.864,735,921,663.94,153,051,324.775,004,968,425.68
补充资料:
  净利润-3,410,846,772.45-1,803,329,008.97
  资产减值准备-224,808,627.71-83,959,366.71
  固定资产和投资性房地产折旧-499,497,564.68-300,346,213.46
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-499,497,564.68-300,346,213.46
  无形资产摊销-440,941,860.17-210,989,400.4
  长期待摊费用摊销-10,071,176.02-4,929,866.34
  处置固定资产、无形资产和其他长期资产的损失--2,263,396.06-6,201,002.36
  固定资产报废损失-3,321,403.16-1,867,728.04
  公允价值变动损失---0
  财务费用-76,945,685.71-55,530,243.83
  投资损失-75,923,097.56-35,365,772.99
  递延所得税--136,654,844.97--35,858,881.65
  其中:递延所得税资产减少--163,235,635.39--35,423,070.01
    递延所得税负债增加-26,580,790.42--435,811.64
  存货的减少--828,390,560.68--253,462,220.69
  经营性应收项目的减少--673,323,235.76--517,861,553.48
  经营性应付项目的增加-1,053,848,353.38-758,867,410.03
  其他-521,113.34-2,645,152.79
  现金的期末余额-4,735,921,663.9-5,004,968,425.68
  减:现金的期初余额-4,990,151,186.68-4,990,151,186.68
  加:现金等价物的期末余额---0
  减:现金等价物的期初余额---0
  现金及现金等价物的净增加额--254,229,522.78-14,817,239
公告日期2026-04-242026-04-242025-10-282025-08-20
审计意见(境内)标准无保留意见
TOP↑